U.S. to charge Teva in generic drugs price-fixing probe: Bloomberg Law


Aug 25 (Reuters) - U.S. Justice Department is preparing to charge Teva Pharmaceutical Industries Ltd TEVA.TA with conspiring with competitors to raise prices for generic drugs, Bloomberg Law reported on Tuesday citing a person familiar with the matter.

The decision follows Teva's refusal to agree for a settlement that would have required paying a criminal penalty and admitting wrongdoing, the report said. (

The company declined to comment on the report.

(Reporting By Mrinalika Roy in Bengaluru; Editing by Vinay Dwivedi)

((; within U.S. +1 646 223 8780, outside U.S. +91 806749 8325;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.